Your browser doesn't support javascript.
loading
Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells.
Thelen, Martin; Keller, Diandra; Lehmann, Jonas; Wennhold, Kerstin; Weitz, Hendrik; Bauer, Eugen; Gathof, Birgit; Brüggemann, Monika; Kotrova, Michaela; Quaas, Alexander; Mallmann, Christoph; Chon, Seung-Hun; Hillmer, Axel M; Bruns, Christiane; von Bergwelt-Baildon, Michael; Garcia-Marquez, Maria Alejandra; Schlößer, Hans Anton.
Afiliação
  • Thelen M; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany martin.thelen@uk-koeln.de.
  • Keller D; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Lehmann J; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Wennhold K; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Weitz H; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Bauer E; Institute of Transfusion Medicine, University of Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Gathof B; Institute of Transfusion Medicine, University of Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Brüggemann M; Klinik für Innere Medizin II, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Kotrova M; Klinik für Innere Medizin II, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Quaas A; Institute of Pathology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Mallmann C; Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Chon SH; Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Hillmer AM; Institute of Pathology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Bruns C; Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • von Bergwelt-Baildon M; Department of Internal Medicine III, University Hospital, Ludwig Maximilians University Munich, München, Germany.
  • Garcia-Marquez MA; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Schlößer HA; Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
J Immunother Cancer ; 10(12)2022 12.
Article em En | MEDLINE | ID: mdl-36600602
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Linfócitos B / Adenocarcinoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Linfócitos B / Adenocarcinoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha